default author photo

Weg M. Ongkeko

University of California, San Diego (UCSD)

9500 Gilman Dr., 0519

La Jolla, CA 92093-0519

United States

  • University of California, San Diego (UCSD)

SCHOLARLY PAPERS

2

DOWNLOADS

164

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Reducing Alzheimer’s Disease Risk in Diabetes: Synergistic Effects of Metformin, GLP-1 Receptor Agonists, and SGLT2 Inhibitors

Number of pages: 22 Posted: 20 Sep 2025
Miski Abdi, Suravi Bajaj, Wei Tse Li, Daniel J. John, Katherine Bangen, Michael Hogarth, Jessica Wang-Rodriguez and Weg M. Ongkeko
University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), affiliation not provided to SSRN, University of California, San Diego (UCSD) and University of California, San Diego (UCSD)
Downloads 82 (809,932)

Abstract:

Loading...

Alzheimer's Disease, Type 2 Diabetes, Metformin, SGLT2 Inhibitors, GLP-1 Receptor Agonist, HbA1c

2.

Differential Survival Outcomes for Common Treatment Modalities of Anaplastic Thyroid Carcinoma: A SEER Population-Based Retrospective Analysis

Number of pages: 29 Posted: 11 Apr 2025
Ruomin Xin, Tianyi Chen, Daniel J. John, Wei Tse Li, Charles S. Coffey, Michael Bouvet, Kevin T. Brumund, Jessica Wang-Rodriguez and Weg M. Ongkeko
University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD), University of California, San Diego (UCSD) - Moores Cancer Center, University of California, San Diego (UCSD), University of California, San Diego (UCSD) and University of California, San Diego (UCSD)
Downloads 82 (796,622)

Abstract:

Loading...

Anaplastic, Thyroid, Cancer, Treatment